炎性乳腺癌:对UICC-AJCC TNM分期系统概念转变的提议
本文指出,在缺乏区分炎性与非炎性乳腺癌的组织学标准时,诊断完全依赖TNM分类中的临床标准;该分类将所有具有炎性特征的未转移患者归为T4d并一律划入3期,转移患者划入4期且不区分炎性特征;作者团队及他人证据提示,诊断时即远处转移(4期)的炎性乳腺癌患者总生存显著降低,据此探讨现行TNM分期是否准确区分炎性与非炎性乳腺癌。
要点
- 炎性乳腺癌诊断依赖TNM分类的临床标准,无组织学区分标准。
- 非转移炎性乳腺癌一律归为T4d和3期,不论肿瘤大小或淋巴结扩散。
- 转移性炎性乳腺癌归为4期,TNM分类不依据炎性标准区分患者。
核心结论
- 本文探讨现行TNM分期分类是否能准确区分炎性与非炎性乳腺癌患者。
研究设计与样本
- 本文为Personal View(个人观点)文章,基于作者团队及他人的证据进行论述。
主要发现
- 非转移炎性乳腺癌患者全部归为T4d和3期,不论肿瘤大小或淋巴结扩散。
- 转移性炎性乳腺癌患者归为4期,TNM分类不依据炎性标准区分患者。
- 作者团队及他人证据提示,诊断时即远处转移(4期)的炎性乳腺癌患者总生存显著降低。
关键数值与推荐
- TNM分类将具有炎性乳腺癌临床特征的患者限于T4d亚类。
- 非转移炎性乳腺癌患者一律归为3期。
- 转移性炎性乳腺癌患者归为4期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the absence of histological criteria that distinguish between inflammatory and non-inflammatory breast cancer, diagnosis of inflammatory breast cancer relies entirely on the existence of clinical criteria as outlined by the TNM classification. This classification restricts patients presenting with clinical criteria characteristic of inflammatory breast cancer to subcategory T4d, which immediately relegates all patients with non-metastatic inflammatory breast cancer to stage 3, regardless of tumour size or nodal spread. Patients who present with metastatic disease are consigned to stage 4, and the TNM classification does not distinguish patients on the basis of the presence of inflammatory criteria. Evidence by our group and others suggests that patients with inflammatory breast cancer have significantly reduced overall survival among those who present with distant metastasis at diagnosis (stage 4). In light of these results, this Personal View addresses whether the current TNM staging classification accurately represents a distinction between patients with inflammatory and those with non-inflammatory breast cancer.
引用
- Fouad TM, Barrera AMG, Reuben JM, et al. Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system. Lancet Oncol. 2017. PMID: 28368261. doi:10.1016/S1470-2045(17)30192-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。